Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Abstract Despite centuries since the discovery and study of cancer, cancer is still a lethal and intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much attention as a pivotal component of the tumor microenvironment. The versatility and sophisticated mechanisms of C...

Full description

Bibliographic Details
Main Authors: Hao Zhang, Xinghai Yue, Zhe Chen, Chao Liu, Wantao Wu, Nan Zhang, Zaoqu Liu, Liping Yang, Qing Jiang, Quan Cheng, Peng Luo, Guodong Liu
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-023-01860-5
_version_ 1797577639628636160
author Hao Zhang
Xinghai Yue
Zhe Chen
Chao Liu
Wantao Wu
Nan Zhang
Zaoqu Liu
Liping Yang
Qing Jiang
Quan Cheng
Peng Luo
Guodong Liu
author_facet Hao Zhang
Xinghai Yue
Zhe Chen
Chao Liu
Wantao Wu
Nan Zhang
Zaoqu Liu
Liping Yang
Qing Jiang
Quan Cheng
Peng Luo
Guodong Liu
author_sort Hao Zhang
collection DOAJ
description Abstract Despite centuries since the discovery and study of cancer, cancer is still a lethal and intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much attention as a pivotal component of the tumor microenvironment. The versatility and sophisticated mechanisms of CAFs in facilitating cancer progression have been elucidated extensively, including promoting cancer angiogenesis and metastasis, inducing drug resistance, reshaping the extracellular matrix, and developing an immunosuppressive microenvironment. Owing to their robust tumor-promoting function, CAFs are considered a promising target for oncotherapy. However, CAFs are a highly heterogeneous group of cells. Some subpopulations exert an inhibitory role in tumor growth, which implies that CAF-targeting approaches must be more precise and individualized. This review comprehensively summarize the origin, phenotypical, and functional heterogeneity of CAFs. More importantly, we underscore advances in strategies and clinical trials to target CAF in various cancers, and we also summarize progressions of CAF in cancer immunotherapy.
first_indexed 2024-03-10T22:11:58Z
format Article
id doaj.art-0900cb5906e549e598fde1afa43cc578
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-03-10T22:11:58Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-0900cb5906e549e598fde1afa43cc5782023-11-19T12:34:20ZengBMCMolecular Cancer1476-45982023-10-0122115010.1186/s12943-023-01860-5Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trialsHao Zhang0Xinghai Yue1Zhe Chen2Chao Liu3Wantao Wu4Nan Zhang5Zaoqu Liu6Liping Yang7Qing Jiang8Quan Cheng9Peng Luo10Guodong Liu11Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Neurosurgery, Central Hospital of ZhuzhouDepartment of Oncology, Xiangya Hospital, Central South UniversityCollege of Life Science and Technology, Huazhong University of Science and TechnologyDepartment of Interventional Radiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Laboratory Medicine, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Urology, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Neurosurgery, Xiangya Hospital, Central South UniversityDepartment of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical UniversityDepartment of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical UniversityAbstract Despite centuries since the discovery and study of cancer, cancer is still a lethal and intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much attention as a pivotal component of the tumor microenvironment. The versatility and sophisticated mechanisms of CAFs in facilitating cancer progression have been elucidated extensively, including promoting cancer angiogenesis and metastasis, inducing drug resistance, reshaping the extracellular matrix, and developing an immunosuppressive microenvironment. Owing to their robust tumor-promoting function, CAFs are considered a promising target for oncotherapy. However, CAFs are a highly heterogeneous group of cells. Some subpopulations exert an inhibitory role in tumor growth, which implies that CAF-targeting approaches must be more precise and individualized. This review comprehensively summarize the origin, phenotypical, and functional heterogeneity of CAFs. More importantly, we underscore advances in strategies and clinical trials to target CAF in various cancers, and we also summarize progressions of CAF in cancer immunotherapy.https://doi.org/10.1186/s12943-023-01860-5CAFClinical trialMicroenvironmentImmunotherapyTarget
spellingShingle Hao Zhang
Xinghai Yue
Zhe Chen
Chao Liu
Wantao Wu
Nan Zhang
Zaoqu Liu
Liping Yang
Qing Jiang
Quan Cheng
Peng Luo
Guodong Liu
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Molecular Cancer
CAF
Clinical trial
Microenvironment
Immunotherapy
Target
title Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
title_full Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
title_fullStr Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
title_full_unstemmed Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
title_short Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
title_sort define cancer associated fibroblasts cafs in the tumor microenvironment new opportunities in cancer immunotherapy and advances in clinical trials
topic CAF
Clinical trial
Microenvironment
Immunotherapy
Target
url https://doi.org/10.1186/s12943-023-01860-5
work_keys_str_mv AT haozhang definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT xinghaiyue definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT zhechen definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT chaoliu definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT wantaowu definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT nanzhang definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT zaoquliu definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT lipingyang definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT qingjiang definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT quancheng definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT pengluo definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials
AT guodongliu definecancerassociatedfibroblastscafsinthetumormicroenvironmentnewopportunitiesincancerimmunotherapyandadvancesinclinicaltrials